Based on Theory of "Deficiency of Qi and Stagnation" to Explore Pathogenesis of Chronic Renal Failure "Micro-inflammatory State" and Progress of Traditional Chinese Medicine Prevention and Treatment / 中国实验方剂学杂志

Chronic renal failure （CRF） is generally characterized by micro-inflammatory state， which can aggravate the CRF process in severe cases， leading to the deterioration of renal function， malnutrition， anemia and other complications. Therefore， it is of great significance to improve the micro-inflammatory state of CRF. "Deficiency of Qi and stagnation" is the basic pathogenesis of the micro-inflammatory state of CRF， which runs through the whole process of the disease and affects the formation and outcome of CRF in different forms. Traditional Chinese medicine （TCM） has unique advantages in improving the micro-inflammatory state and enhancing the immunity of the body due to its advantages of syndrome differentiation and treatment， strengthening the righteousness and eliminating pathogenic factors. Therefore， the author systematically sorted out the relationship between micro-inflammatory state and CRF， understanding of micro-inflammatory state of CRF and its prevention and treatment of TCM by referring to relevant literature， based on the theory of "deficiency of Qi and stagnation"， and proposed that spleen and kidney failure （deficiency of Qi） is the origin of micro-inflammatory state of CRF， and blood stasis and poisonous evil （stagnation） is the target of its onset. Deficiency of Qi and stagnation adhered to each other， acted as cause and effect， and developed in a spiral manner throughout the development of the disease. TCM has the effects of nourishing the spleen and kidney， removing blood stasis and turbidity. By down-regulating C-reactive protein （CRP）， interleukin-6 （IL-6）， tumor necrosis factor alpha （TNF-α） and other micro-inflammatory indicators， it can eliminate the pathological wastes derived from spleen and kidney deficiency， reduce the micro-inflammatory state， restore the balance of Yin and Yang in the body to achieve the purpose of eliminating pathogens and protecting renal function， providing guidance for the clinical treatment of CRF.

Cistatina C: marcador de laboratorio precoz de enfermedad renal en pacientes con depranocitosis / Cystatin C: early laboratory marker of renal disease In sickle cell disease

La enfermedad renal en el paciente con drepanocitosis es una consecuencia de su complejo proceso fisiopatológico, por lo que es importante disponer de un grupo de parámetros de laboratorio que, junto a la evaluación clínica, permita determinar de forma precoz la presencia de esta complicación. La cistatina C ha demostrado ser uno de los parámetros que con mayor exactitud aporta evidencia temprana de daño renal en este grupo de pacientes y al mismo tiempo constituye un posible indicador de pronóstico de gran importancia(AU)

Renal disease in patients with sickle cell disease is a consequence of its complex pathophysiological process, so it is important to have a set of laboratory parameters that, together with the clinical evaluation, allow the early detection of this complication. Cystatin C has been shown to be one of the parameters that provides, with greater accuracy, early evidence of kidney damage in this group of patients and at the same time constitutes a possible indicator of prognosis of great importance(AU)

Blood Urea & Salivary Urea levels in End Stage Renal Failure.

Elevation of Blood Urea Nitrogen in renal diseases results concomitant increase in Salivary Urea levels. Aims : Determine if there was any correlation between the Salivary Urea levels with that of Blood Urea levels. Material & Methods : samples of blood and saliva were taken from Hemodialysis and control groups to assess the Blood Urea Nitrogen (BUN) and Salivary Urea (SU) levels respectively under strict aseptic precautions. Informed consent was taken from patients and ethical committee approval taken. Results : showed no statistically significant difference between Blood Urea and Salivary Urea in the Hemodialysis group (p>0.05). There was a statistically significant difference between Hemodialysis group and Control group with respect to Blood Urea and Salivary Urea levels. (p<0.001). Conclusion : saliva can be used as a noninvasive diagnostic marker tool.

Antioxidants deficiency: a sensitive indicator of cardiometabolic risk in chronic renal failure.

Background: Antioxidant depletion occurring in chronic renal failure patients is an important cause of associated morbidity & mortality, which in turn imposes a great socioeconomic burden of health care. Early diagnosis & targeted management of this preventable deficiency may have a positive impact on the management of co morbidities associated with chronic renal failure. Aims & Objectives: To evaluate the status of antioxidants as an early indicator of cardiometabolic risk in chronic renal failure patients. Settings & Design: This was a randomised case Control study including 10 controls of either sex with normal renal function between age group 20-60 years and 15 patients of chronic renal failure on dialysis between the age group of 16 - 60 years. Methods: 12 hour fasting venous blood samples were collected from all the participants and were assayed for various antioxidants. Statistical analysis: Results were analyzed by unpaired t test, p value was determined & Correlation coefficient was calculated amongst various parameters. Results: In the present study, significantly low levels of vitamin C ( Cases: 0.367 ± 0.13 mg/dl controls: 1.324 ± 0.61 mg/dl; p < 0.01) & vitamin E (cases: 0.235 ± 0.102 mg/dl, controls (0.854 ± 0.28 mg/dl; p < 0.01) were observed in chronic renal failure patients as compared to controls. Conclusion: Diminished levels of Vitamin C & E in our study may be an indicator of increased oxidative stress which can be a responsible factor for increased incidence of cardiovascular complications. Supplementing these patients with recommended dosage of these vitamins may provide an essential tool to reduce the burden of suffering.

Ruptura bilateral y espontánea del tendón del cuadríceps / Ruptura bilateral y espontánea del tendón del cuadríceps

Estudio retrospectivo, transversal y analítico de 5 pacientes ingresados en el equipo 3 del Servicio de Ortopedia y Traumatología en el Hospital Central de San Cristóbal, estado Táchira. Venezuela, con diagnósticos de Ruptura Bilateral del Tendón del Cuádriceps, en el periodo comprendido entre enero del 2004 a julio del 2007. La ruptura espontánea del tendón del cuádriceps es una patología asociada a enfermedades crónicas metabólicas. La ruptura suele ser unilateral y en raras ocasiones bilateral. Se presentan 5 casos de ruptura bilateral de tendón del cuádriceps en pacientes con insuficiencia renal crónica (IRC). El diagnóstico se hace fundamentalmente por la clínica de dolor súbito, seguido de incapacidad para la extensión de la rodilla y defecto palpable por encima de la patela. El estudio radiológico no aporta mayores datos y la ecografía confirma la lesión en todos los casos, pero con un mal reporte de la extensión de la lesión. Los 5 casos estudiados se resolvieron con tratamiento quirúrgico, con una buena evolución, según la escala de gradación de Lovett(AU)

Retrospective, transversal and analytical histories study of the 5 patients admitted in the team 3 of the trauma service in the Central Hospital, San Cristobal-Táchira State, Venezuela with diagnostic of bilateral rupture of the quadriceps tendon, in the period between january 2004 and july 2007. The spontaneous rupture of the quadriceps tendon is a pathology associated with chronic metabolic diseases. The rupture usually is unilateral and rarely bilateral. There are 5 cases of bilateral rupture of quadriceps tendon in 5 patients with chronic renal failure. The diagnostic is mainly due to the sudden pain clinic, followed by the inability of knee extension and the palpable defect above the patela. The radiological study not provide further details and the ultrasound confirmed the injury in all the cases, but the ultrasound give wrong information about the extent of the injury. The 5 studied cases were solve with surgical treatment, with a Good outcome according to the scale of gradation of Lovett(AU)

Insuficiencia renal crónica terminal y hemodiálisis: Alteraciones endoscópicas e histológicas del tracto gastrointestinal

Objetivos: Determinar la frecuencia de alteraciones endoscópicas e histológicas del tracto digestivo en pacientes con IRC-T en hemodiálisis. Determinar la relación entre la presencia de síntomas y los hallazgos endoscópicos. Métodos: Estudiamos 55 pacientes con IRC-T en hemodiálisis en protocolo pretrasplante renal y 55 pacientes de la consulta de gastroenterología. Se realizó EDS y colonoscopia, con toma de biopsia independientemente de la presencia o no de lesiones. Se utilizó el X2 para las variables cualitativas con un valor de p<0.05, se realizó el cálculo del 95% intervalo de confianza. Resultados: De los 110 pacientes 70% presentó alteraciones en la EDS, de éstos 44.5% eran pacientes con IRC-T y 25.5% eran controles. La diferencia fue estadísticamente significativa (p<0.0001). El hallazgo histológico más frecuente fue gastritis crónica activa. Predominaron los cambios inflamatorios de la mucosa sobre la enfermedad ulcerosa. No hubo diferencia significativa en la EDI. Los pólipos de colon y adenomas tubulares fueron más frecuentes en los pacientes con IRC-T. Conclusiones: Las lesiones gastrointestinales son más frecuentes en pacientes con IRC-T. Es necesaria la realización de estudios endoscópicos pre-transplante renal.

Objectives: To determine the frequency of endoscopic and histological changes in the digestive tract in patients with CRF-T in hemodialysis treatment and, to determine the relationship between the presence of symptoms and endoscopic findings. Methods: 55 patients in hemodialysis were studied with T-IRC on pre - kidney transplant protocol and, 55 patients from the gastroenterology unit. Upper endoscopy (UE) and colonoscopy with biopsy samples were performed, regardless of the presence of injuries. X2 was used for qualitative variables with a p-value <0.05, with 95% confidence interval. Results: Of 110 patients 70% had UE abnormalities, of which 44.5% were IRC - T patients and 25.5% were controls. The difference was statistically significant (p <0.0001). The most common histological finding was active chronic gastritis. Inflammatory changes of the mucosa predominated over ulcerative disease. There were no significant differences regarding colonoscopy. Colon polyps and tubular adenomas were more common in patients with CRF-T. Conclusions: Gastrointestinal lesions are more common in patients with CRF-T. Endoscopic evaluation in Pre - renal transplant patients are necessary.

Observation of Curative Efficacy of Shenkang Injection for Chronic Renal Failure / 中国药房

OBJECTIVE:To observe the clinical efficacy of Shenkang injection,a new compound preparation for chronic renal failure(CRF).METHODS:A total of 84 CRF patients were randomly divided into two groups:the treatment group(n=54)was given routine antihypertensive therapy and infused(iv gtt)with Shenkang injection 60～ 100mL(dissolved in 10% GS 300mL or NS 300mL)q.d for 30d;the control group(n=30)was infused(iv gtt)with Compound danshen injection 250mL q.d for 30d.RESULTS:As compared with the control group,serum levels of creatinine and urea nitrogen(UN)in treatment group had a greater reduction(P

The Stability of Peritoneal Dialysis for the Treatment of Chronic Renal Failure in Cirrhotic Patients Acompanying Ascites / 대한신장학회지

PURPOSE: When liver cirrhosis patients accompanying ascites need renal replacement therapy because of chronic renal failure (CRF), peritoneal dialysis (PD) can allow direct removal of ascites and prevent anticoagulants use. However, since PD might aggravate hypoalbuminemia and increase chances of peritonitis, clinicians tend to hesitate to apply it to those patients. The aim of the present study is to assess the outcome and stability of PD for the treatment of CRF patient with cirrhosis acompanying ascites. METHODS: A retrospective study based on the clinical records was performed in cirrhotic patients with ascites in whom PD was performed for the treatment of CRF and who were followed up at Samsung Medical Center unit, between January 1995 and July 2005. RESULTS: In our study, 15 patients were enrolled. Child-pugh class was worse in non-survival group than survival group (p<0.01). One-year patient survival was 40% in Class C and 75% in Class B, and patient survival differed between Class C and Class B (p=0.0014). Causes of death were terminal liver failure (n=6) and sepsis due to pneumonia (n=1). Total 27 episodes of peritonitis occurred, and the peritonitis rates were 0.91 episodes/patients-year. CONCLUSION: Although the peritonitis rates turned out somewhat high, the use of PD for the treatment of CRF in patients with liver cirrhosis accompanying ascites seems to be safe and effective. Main cause of death in our study seems to be related to liver disease.

Study on The Effects of Chronic Renal Failure on Hearing and Its Mechanism / 浙江中医药大学学报

[Objective]To observe the effects of chronic renal failure (CRF)on hearing and investigate its mechanism.[Methods] Twenty-nine male wistar rats were randomly divided into four groups:Ⅰthe normal rats as control for 12 days (n=6); Ⅱrats given adenine(ig) for 12 days (n=8); Ⅲthe normal rats as control for 24 days (n=6);Ⅳ rats given adenine(ig) for 24 days(n=9). The rat model of CRF was produced by being perfused of adenine [300mg/kg]for 12d and 24d. Brain-stem auditory evoked potential(BAEP) was utilized to evaluate the auditory function and renal tissue morphology was observed; Serum sampling was used to determine the content of Cr, BuN. The expression of NOSⅡin the cochlear was measured by immunohistochemical technique.[Results] After adenine given for 12d or 24d, the Cr and BuN were in significant higher level than that in control group. The BAEP thresholds were gradually higher than that in control group, the BAEP delitescence prolonged. Light microscopic observation of renal tissue showed that the degree of fibrosis was gradually higher. Data of immune histochemistry about the cochlear tissue showed that the expressions of NOSⅡ were feebly positive in the cochlear vassal texture, inner-outer hairy cell and helical-ganglion cell, and following functional damage of the kidney, their expressions reinforced gradually, amongst which strongest expression was vassal texture, the next helical-ganglion cell, the last inner-outer hairy cell.[Conclusion]CRF can result in deafness. It is likely concerned with toxic effects of the metabolizable substance, the metabolizable dysfunction of the electrolyte, shortage of trace elements, etc. One of the important mechanisms of the effects of CRF on hearing is the toxic damage of NO to cochlea.

Clinical Observation of Zishen Huoxue Jiedu Method for the Treatment of Chronic Renal Failure / 中国中医药信息杂志

Objective To observe the therapeutic effect of the Zishen Huoxue Jiedu (ZSHXJD) method on patients with chronic renal failure (CRF). Methods 252 cases of CRF were treated by ZSHXJD method. TCM symptom, the serum level of Cr, BUN, ET, ANP, IL-8, ?2-mg, HGB and level of urine protein were detected. Results After the treatment, TCM symptom, the level of Cr, BUN, ET, ANP, IL-8, ?2-mg and urine protein were found markedly lower than that before the treatment (P

A Case of ReVersible Posterior Leukoencephalopathy Syndrome (RPLS) in a Patients with Chronic Renal Failure / 대한신장학회잡지

The reVersible posterior leukoencephalopathy syndrome (RPLS) describes a syndrome of headaches, confusion, seizures, and visual disturbances associated with transient, predominantly posterior cerebral lesions revealed by neuroimaging. RPLS has been associated clinically with hypertension, immunosuppression, and known triggers include acute renal failure, eclampsia, cyclosporine, and lupus. We report a 45-year-old male with chronic renal failure showed RPLS following hemodialysis and review literatures.

Is Pretransplant Bladder Augmentation Using Hydrostatic Pressure of Contracted Bladder in Chronic Renal Failure Really Effective? / 대한이식학회지

PURPOSE: Kidney transplantation is definite treatment in chronic renal failure (CRF). But CRF patients have contracted bladder due to disuse atrophy and fibrosis of bladder mucosa and muscle. Contracted bladder results in CRF itself and failure of transplantation. And this causes many difficulties in ureteroneocystostomy. So many authors suggest that preoperative bladder augmentations of contracted bladder (cystoplasty) using intestine increase success rate in kidney transplantation. But these methods have been usually studied in pediatric transplantation. Preoperative hydrostatic bladder dilatation is nonoperative treatment usually used in interstitial cystitis and hemorrhagic bladder tumor. METHODS: Since January 1996, we newly attempted pretransplant bladder augmentation using hydrostatic pressure in 22 CRF patients who had contracted bladder diagnosed through preoperative voiding cystourethrogram (VCUG). RESULTS: Pre-augmented average bladder volume was 87.7 mL (60~100 mL) and post-augmented bladder volume was 210.5 mL (100~250 mL). There was no complication associated with pretransplant bladder augmentation itself, and there was no transplanted kidney loss. CONCLUSION: These results suggest that pretransplant bladder augmentation using hydrostatic pressure be useful in kidney transplantation of CRF patient who had contracted bladder.

Electroretinograms in Chronic Renal Failure Patients with Diabetic Retinopathy

PURPOSE: To assess retinal function in chronic renal failure (CRF) by comparing the electroretinograms (ERGs) of CRF patients with diabetic retinopathy and those of diabetic retinopathy patients with normal renal function. METHODS: 63 eyes of 35 diabetic patients of diabetic retinopathy with CRF (group 1) and 86 eyes of 60 diabetic patients of diabetic retinopathy with normal renal function (group 2) were studied retrospec-tively. Eyes with vitreous hemorrhage, cataract and/or another ocular abnormalities were excluded. A fluorescein angiogram was performed in each patient to determine the stage of diabetic retinopathy and ERGs were performed to identify the differences between the groups. RESULTS: Of the 63 eyes in group 1, 44 were in the non-proliferative stage (group 1-N) and 19 proliferative (group 1-P). Of the 86 eyes in group 2, 52 were non-proliferative (group 2-N) and 34 proliferative (group 2-P). The group 1 a- and b-wave amplitude decreased significantly compared with group 2 (P0.05). CONCLUSION: With the comparison of ERGs, We found the degree of retinal damage is more severe in diabetic retinopathy patients who have CRF than those who have normal renal function.

The Efficacy and Safety of Intravenous Iron Sucrose in Hemodialysis Patients / 대한신장학회잡지

BACKGROUND: The objective of the present study was to assess the efficacy and safety of iron sucrose by determining the subsequent change in hemoglobin (Hgb), hematocrit (Hct), transferrin saturation (TAST), serum ferritin values and blood pressures in hemodialysis patients receiving Epoetin. METHODS: A total of 19 adult patients who had been receiving hemodialysis three times a week at Chonnam Natinal University Hospital were assigned. Their Hgb level was less than 10 g/dL and their serum ferritin level was less than 100 ng/mL, and/or TSAT was less than 20%. Iron sucrose was administered as 1,000 mg in 10 divided doses diluted in 100 mL normal saline over the last 60 minutes during hemodialysis with a one-time prior test dose of 20 mg on 10 consecutive dialysis sessions. Iron sucrose dosage was adjusted to 25-100 mg/week depending on serum ferritin level, and TSAT in the following 3 months. Epoetin administration was stopped due to insurance regulation when Hgb level was more than 10 g/dL and Hct level was more than 30 %. To evaluate efficacy of iron sucrose, assessment of serum iron parameters and anemia indices was determined just before the first dose (baseline), at 1 month after the first dose (loading) and then, monthly for 3 months (maintenance). To evaluate safety of iron sucrose, we recorded blood pressure 1 hour before and at the time of completion of iron sucrose injection, and also recorded blood pressure during observation sessions before dialysis and at intervals of 2 hours and 4 hours after starting dialysis. We determined routine serum chemistry and hematologic results at 1 month after the first dose and compared results with those obtained at baseline. RESULTS: 1,000 mg iron surcose injection in 10 divided dose (loading) produced a significant rise in Hgb, Hct, serum iron, serum ferritin, TSAT, MCV and MCH at 1 month after first dose (respectively p<0.001, p<0.001, p<0.01, p<0.001, p<0.01, p<0.01, p< 0.01). During the following maintenance period of 3 months, Hgb, Hct, serrum ferritin, and TSAT level remained more elevated than at baseline respectively. In 19 enrolled patients, we experienced no serious adverse drug reactions and no significant changes in intradialytic blood pressure associated with iron sucrose administration. Serum albumin concentrations was higher at 1 month than at base line and however, changes in other serum chemistry and hematologic results were not statistically significant. CONCLUSION: Intravenous iron sucrose administration is an efficient and safe method to supply iron in end-stage renal disease patients receiving Epoetin with iron deficiency, who are undergoing hemodialysis.

Treatment of Aneurysmal SAH with CRF

There are several difficulties in treating aneurysmal subarachnoid hemorrhage(SAH) with chronic renal failure(CRF). First, fluid therapy is not feasible especially in vasospasm. Second, hypertonic solution therapy used to reduce intracranial pressure(ICP) is restricted. Third, hemorrhage2) and disequilibrium syndrome1)2)9) associated hemodialysis can occur. In this article, the authors experienced two cases of aneurysmal SAH with CRF. The first patient was a 57-year old man who suffered from CRF for 8 years. Magnetic resonance angiography had demonstrated a middle cerebral artery(MCA) bifurcation aneurysm on right side. He was treated with early surgery and recovered without neurological deficits. The second patient was a 43-year old woman who suffered from CRF for 5 years. Posterior communicating artery(P-Com) aneurysm was identified on the left side and delayed surgery was performed. After operation, vasospasm occurred and she died of brain swelling from infraction on the left MCA territory. It is noteworthy that the most important factor in aneurysmal SAH with CRF is the prevention vasospasm, because the use of fluid and hypertonic solution therapy is not feasible. To prevent vasospasm, early operation is warranted for the removal of SAH during operation. Non-anticoagulant agent hemodialysis is used during pre and post operative period.

Clinical researches that the serum NO、ET、IL-6 varieties of chronic renal failure patients with blood stasis symptom and effect of Lei's Danshen Tablets / 中成药

AIM: To observe the changes of serum NO、ET、IL-6 of chronic renal failure (CRF) patients with blood stasis symptom and the relation between renal function and the change of traditional Chinese medicine(TCM) symptom,and the curative efficacy of Lei's Danshen Tablets (LDT). METHODS: At first,The levels of serum NO、ET、IL-6 and renal function of 60 non-dialysis patients with CRF of blood stasis symptom were mensurated, meanwhile the syndrome points of TCM were observed.The relativity was analysed after lineal relation of among these points were set up.Secondly,sixty cases were randomly divided into two groups,30 cases in the control group were given conventional treatment,30 cases in the treatment group were given Lei's Danshen Tablets in addition to the conventional treatment.The levels of serum NO、ET、IL-6 and renal function were observed after therapy. RESULTS:The levels of serum NO、ET、IL-6 of CRF patients with blood stasis symptom were obviously positive or negative relation with Scr and TCM smptom;LDT could improve renal function and blood stasis symptoms (P